Market Overview

20 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stock rose 45.27% to $9.82 during Monday's pre-market session. The most recent rating by H.C. Wainwright, on Mar 30, is at Buy, with a price target of $24.

Aurora Cannabis, Inc. (NYSE:ACB) shares rose 30.28% to $14.20. The most recent rating by Piper Sandler, on May 15, is at Neutral, with a price target of $10.

Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) stock rose 23.70% to $1.67.

Fulgent Genetics, Inc. (NASDAQ:FLGT) stock rose 23.25% to $20.20. The most recent rating by Credit Suisse, on May 5, is at Neutral, with a price target of $11.

Kitov Pharma, Inc. (NASDAQ:KTOV) stock moved upwards by 22.10% to $0.60.

Trevena, Inc. (NASDAQ:TRVN) shares rose 12.38% to $1.18.

Vir Biotechnology, Inc. (NASDAQ:VIR) shares increased by 11.30% to $33.78. The most recent rating by Baird, on Mar 27, is at Underperform, with a price target of $20.

Auris Medical Holding, Inc. (NASDAQ:EARS) shares rose 11.21% to $1.19.

HEXO, Inc. (NYSE:HEXO) shares increased by 10.99% to $0.59. The most recent rating by Roth Capital, on Mar 31, is at Neutral, with a price target of $1.

Mesoblast, Inc. (NASDAQ:MESO) stock rose 9.88% to $13.01.

 

Losers

ChemoCentryx, Inc. (NASDAQ:CCXI) shares decreased by 10% to $48.42 during Monday's pre-market session. The most recent rating by JP Morgan, on May 14, is at Overweight, with a price target of $64.

PDL BioPharma, Inc. (NASDAQ:PDLI) stock fell 8.81% to $2.90.

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares decreased by 7.64% to $0.25.

Tetraphase Pharmaceutical, Inc. (NASDAQ:TTPH) stock declined 6.85% to $2.04. According to the most recent rating by Gabelli & Co., on Mar 17, the current rating is at Sell.

Aptevo Therapeutics, Inc. (NASDAQ:APVO) shares fell 6.40% to $5.12.

PLx Pharma, Inc. (NASDAQ:PLXP) shares declined 6.25% to $2.55.

Seneca Biopharma, Inc. (NASDAQ:SNCA) shares decreased by 5.98% to $0.86.

Atossa Therapeutics, Inc. (NASDAQ:ATOS) stock fell 5.88% to $1.60.

Menlo Therapeutics, Inc. (NASDAQ:MNLO) shares fell 5.33% to $1.60. The most recent rating by HC Wainwright & Co., on May 12, is at Buy, with a price target of $2.

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) shares decreased by 5% to $0.38.

 

Related Articles (SRNE + ACB)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas